Timur Cerić

A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)

Suresh S. Ramalingam, Glenwood Goss, Rafael Rosell et al. · Annals of Oncology · 2015 · 106 citations · Full text

Oncology, Heat Shock, Medicine +7

Use of the Depression, Anxiety and Stress Scale (DASS-21) Questionnaire to Assess Levels of Depression, Anxiety, and Stress in Healthcare and Administrative Staff in 5 Oncology Institutions in Bosnia and Herzegovina During the 2020 COVID-19 Pandemic

Inga Marijanović, Marija Kraljević, Teo Buhovac et al. · Medical Science Monitor · 2021 · 62 citations · Full text

Pregnancy After Breast Cancer in Young <i>BRCA </i>Carriers

Matteo Lambertini, Eva Blondeaux, Elisa Agostinetto et al. · JAMA · 2023 · 49 citations · Full text

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Joseph Gligorov, Beyhan Ataseven, Mark Verrill et al. · European Journal of Cancer · 2017 · 46 citations

Breast Oncology, Medicine, Primary Analysis +7

Randomized trial of sequence vs. combination of capecitabine (X) and docetaxel (T): XT vs. T followed by X after progression as first-line therapy for patients (pts) with metastatic breast cancer (MBC)

S. Beslija, H. Basic, Aida Tatarević et al. · Journal of Clinical Oncology · 2006 · 29 citations

First-line Therapy, Breast Oncology, Cancer Management +18